+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Canada Neuromodulation Devices Market Outlook to 2025

  • ID: 4668139
  • Report
  • November 2018
  • Region: Canada
  • 30 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific Corp
  • LivaNova PLC
  • Medtronic Plc
  • Nevro Corp
  • MORE
Canada Neuromodulation Devices Market Outlook to 2025

Summary

the new report, Canada Neuromodulation Devices Market Outlook to 2025, provides key market data on the Canada Neuromodulation Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS).

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Neuromodulation Devices market segments - Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS)..
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Neuromodulation Devices market.
  • Global corporate-level profiles of key companies operating within the Canada Neuromodulation Devices market.
  • Key players covered include Abbott Healthcare Pvt Ltd, Boston Scientific Corp, Medtronic plc and others.
Reasons to Buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific Corp
  • LivaNova PLC
  • Medtronic Plc
  • Nevro Corp
  • MORE
1 Table of Contents

2 Introduction
2.1 What Is This Report About?
2.2 Neuromodulation Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Neuromodulation Devices Market, Canada
3.1 Neuromodulation Devices Market, Canada, Revenue ($m), 2015-2025
3.2 Neuromodulation Devices Market, Canada, Volume (Units), 2015-2025
3.3 Neuromodulation Devices Market, Canada, Average Price ($), 2015-2025
3.4 Neuromodulation Devices Market, Canada, Distribution Share by Revenue ($m), 2017
3.5 Neuromodulation Devices Market, Canada, Company Share by Revenue ($m), 2017

4 Overview of Key Companies in Canada, Neuromodulation Devices Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Boston Scientific Corp
4.2.1 Company Overview
4.3 Nevro Corp
4.3.1 Company Overview
4.4 LivaNova PLC
4.4.1 Company Overview
4.5 Abbott Laboratories
4.5.1 Company Overview

5 Neuromodulation Devices Market Pipeline Products

6 Recent Developments
6.1 Financial Announcements
6.1.1 Oct 30, 2017: Ergoresearch announces its results for fiscal year 2017

7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Distribution Share Analysis
7.1.7 Benchmarking
7.2 Consulting
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Neuromodulation Devices Market, Canada, Revenue ($m), USD Constant, 2015-2020
Table 2: Neuromodulation Devices Market, Canada, Revenue ($m), USD Constant, 2021-2025
Table 3: Neuromodulation Devices Market, Canada, Volume (Units), 2015-2020
Table 4: Neuromodulation Devices Market, Canada, Volume (Units), 2021-2025
Table 5: Neuromodulation Devices Market, Canada, Average Price ($), 2015-2020
Table 6: Neuromodulation Devices Market, Canada, Average Price ($), 2021-2025
Table 7: Neuromodulation Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2017
Table 8: Neuromodulation Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2017
Table 9: Neuromodulation Devices Market Pipeline Products
Table 10: Total Number of Primary Research Participants, Neurology Devices Market, by Country

List of Figures
Figure 1: Neuromodulation Devices Market, Canada, Revenue ($m), USD Constant, 2015-2025
Figure 2: Neuromodulation Devices Market, Canada, Volume (Units), 2015-2025
Figure 3: Neuromodulation Devices Market, Canada, Company Share (%) 2017
Note: Product cover images may vary from those shown
3 of 3
  • Medtronic Plc
  • Boston Scientific Corp
  • Nevro Corp
  • LivaNova PLC
  • Abbott Laboratories
Note: Product cover images may vary from those shown
Adroll
adroll